Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Zurich
About this trial
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Eligibility criteria
Qualifiers
CT SCAN for pulmonary nodule detection/follow up
CT SCAN for pneumonia detection/follow up
Disqualifiers
under 18
BMI over 30
Trial design
Treatments tested in this trial
- Computed Tomography
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov